Liver failure after long-term nucleoside antiretroviral therapy [2]

Lancet

Volumn 358, Issue 9283, 2001, Pages 759-760

  Kronenberg, A ^a   Riehle, H M ^a   Gunthard H F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 1 ANTITRYPSIN; AMINOTRANSFERASE; BILIRUBIN; CD4 ANTIGEN; CERULOPLASMIN; DIDANOSINE; ETHAMBUTOL; FERRITIN; GLICLAZIDE; ISONIAZID; LACTIC ACID; METFORMIN; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; STAVUDINE;

ADULT; ANOREXIA; ASCITES; BLOOD CHEMISTRY; CASE REPORT; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; EDEMA; ESOPHAGUS VARICES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; HYPOALBUMINEMIA; LACTIC ACIDEMIA; LETTER; LIVER FAILURE; LIVER FUNCTION; LONG TERM CARE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTHROMBIN TIME; SEROLOGY; SPLENOMEGALY; TUBERCULOUS PERITONITIS; VIREMIA; WEIGHT REDUCTION;

EID: 0035449568     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05910-4     Document Type: Letter

References (3)

1. Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia
2. Delta: A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
3. Management of hyperlactatemia: No need for routine lactate measurements